中文名称: | AZD-2461 | ||||
---|---|---|---|---|---|
英文名称: | AZD-2461 | ||||
别名: | 4-[4-氟-3-[(4-甲氧基哌啶-1-基)羰基]苄基]酞嗪-1(2H)-酮 4-(4-fluoro-3-(4-methoxypiperidine-1-carbonyl)benzyl)phthalazin-1(2H)-one | ||||
CAS No: | 1174043-16-3 | 分子式: | C22H22FN3O3 | 分子量: | 395.43 |
CAS No: | 1174043-16-3 | ||||
分子式: | C22H22FN3O3 | ||||
分子量: | 395.43 |
基本信息
产品编号:A11406 |
|||||
产品名称:AZD-2461 |
|||||
CAS: |
1174043-16-3 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
两年 |
||
分子量 |
395.43 |
-20℃ |
一个月 |
||
化学名: |
4-(4-fluoro-3-(4-methoxypiperidine-1-carbonyl)benzyl)phthalazin-1(2H)-one |
||||
Solubility (25°C) |
体外 |
DMSO |
79mg/mL (199.78mM) |
||
Ethanol |
31mg/mL (78.39mM) |
||||
Water |
Insoluble |
||||
体内 |
现配现用 |
|
|||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
2.5289mL |
12.6445mL |
25.2889mL |
5mM |
0.5058mL |
2.5289mL |
5.0578mL |
10mM |
0.2529mL |
1.2644mL |
2.5289mL |
50mM |
0.0506mL |
0.2529mL |
0.5058mL |
生物活性
产品描述 |
一种有效的 PARP 抑制剂,可抑制 PARP1,PARP2 和 PARP3 的活性,IC50 值分别为 5nM,2nM 和 200nM。 |
靶点/IC50 |
PARP |
体外研究 |
AZD2461作用于Pgp比Olaparib亲和力低。 |
体内研究 |
AZD2461作用于抗Olaparib的KB1P肿瘤T6-28,提高Mdr1b表达80倍,不抑制Pgp。AZD2461短期处理携带KB1P肿瘤的小鼠,诱导53BP1表达损失。AZD2461长期处理,具有良好的耐受性,平均无复发生存期延长一倍。 |
推荐实验方法(仅供参考)
细胞实验: |
|
Cell Assay |
BT-20 and SKBr-3 human primary breast cancer cell lines are used in the assay. SKBr-3 cells are cultivated in DMEM medium with 10% FCS and BT-20 in RPMI medium under an atmosphere containing 5% CO2. Twenty four hours after plating (at 60- 70% confluence), the cells are treated with the PARP-1 inhibitors NU1025, AZD-2461, iniparib, olaparib, and rucaparib at concentrations ranging from 50 to 200μM, 5 to 50μM, 5 to 50μM, 1 to 10μM, and 0.3 to 10μM, respectively, for durations indicated in figures 1-7 . |
动物实验: |
|
Animal Administration |
Starting from 2 weeks after transplantation into mice, tumor size is monitored at least 3 times a week. All treatments are started when tumors reach a size of approximately 200mm3. Olaparib (50mg/kg intraperitoneally) and AZD-2461 (100mg/kg per os) are given for 28 consecutive days, unless otherwise indicated. If tumors do not shrink below 50% of the initial volume, treatment is continued for another 28 days; otherwise, a new treatment cycle of 28 days is started when the relapsing tumor reaches a size of 100% of the original volume. AZD-2461 is diluted in 0.5% w/v hydroxypropyl methylcellulose in deionized water to a concentration of 10mg/mL. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )